Marco Donia
@DoniaMarco
Followers
617
Following
1K
Statuses
328
Clinician-Scientist Oncologist @CCITdk, Assoc. Prof. @uni_copenhagen, #immunotherapy #melanoma #RWE #TIL #cancer. Web: https://t.co/WpfTMA5lg9
Copenaghen, Danimarca
Joined June 2018
RT @CCITdk: 🎉Cell Therapy Milestone 👍This week, a patient with melanoma received the first non-viral CRISPR-edited TIL infusion product at…
0
2
0
Subcutaneous anti-PD-1 (nivolumab) approved across solid tumors by FDA (27 Dec 2024) 👉 👍 Important improvement in logistics, but not the first approval of subcutaneous inhibitors of the PD-1/PD-L1 pathway ⌛Several Oral PD-L1 inhibitors in development
0
0
1
@TurajlicLab @IreneLobon @myESMO @GenomicsEngland Privileged to have such fantastic collaborators like @IreneLobon and @TurajlicLab !
0
0
1
@ChristianRolfo @ISEV_Journals @ddemiguelperez @ogarrieta @OSUCCC_James @Susmita62317107 @Al3ssandroRusso @MarisolNeumo Congratulations for this important achievement!
0
0
3
RT @rolfolab: 🚨Our work is open access At @ISEV_JExBio “Extracellular vesicles containing SARS-CoV-2 proteins are associated with multi-or…
0
9
0
Check out the new ESMO Recommendations for the treatment of #Melanoma! Honored to have worked on these Clinical Practice Guidelines with an amazing panel led by @TeresaSAmaral, Olivier Michielin, and @Pascierto
📣 Updated ESMO #ClinicalPracticeGuideline on #CutaneousMelanoma: New recommendations include #neoadjuvanttherapy for #stageIII #melanoma and options for advanced disease based on (neo)adjuvant treatment, disease and patient characteristics. 🔗
0
5
12
Exciting PhD position with an incredible PI 👇
#Tcell death regulation in #cancer is a largely unexplored phenomenon which could be critical for new #immunotherapies. #PhD project that will fill this gap by pushing the boundaries of multimodal #liquid_biopsies supported by the world class @cruk_nbc
0
0
2
Antibody Cancer Therapy: Bispecifics and Multispecifics 👉 Cancer therapy with Abs @NatureRevCancer 👉 Bispecific and multispecific Abs @NatRevClinOncol 👉 The present and future of BsAbs @NatRevDrugDisc
0
0
5
Long-Term Survival in a growing number of cancers at #ESMO24 👉 Press release at (commented by @MdCurioni and me) 1⃣ High-risk, Triple Negative #BreastCancer 2⃣Muscle-invasive #bladdercancer 3⃣Metastatic #Melanoma 🙏 Thanks to @myESMO
0
1
10
0
4
10